Pharmaceutical & Life Sciences News

Warren Seeks Senate Hearing on Generic-Drug Price-Fixing Reports

Dec. 18, 2018, 3:13 PM

Sen. Elizabeth Warren (D-Mass.) called for hearings on allegations of price fixing by generic drug makers, asking Republican committee leaders to investigate the industry alongside ongoing probes by state and federal authorities of more than a dozen companies.

  • In a Dec. 17 letter to Senate colleagues, Warren said “generic drug markets are plagued by anti-consumer behavior and anti-competitive features that go far beyond high-profile price hikes,” with many medications only made by one or two companies.

Key Insights

  • Sustained attention from Republicans and Democrats on drug prices ahead of the 2020 presidential race -- which Warren is likely to enter...
To read the full article log in. To learn more about a subscription click here.